Liśkiewicz Paweł, Pełka-Wysiecka Justyna, Kaczmarczyk Mariusz, Łoniewski Igor, Wroński Michał, Bąba-Kubiś Agata, Skonieczna-Żydecka Karolina, Marlicz Wojciech, Misiak Błażej, Samochowiec Jerzy
Department of Psychiatry, Pomeranian Medical University in Szczecin, Broniewskiego 26, 71-460 Szczecin, Poland.
Department of Clinical and Molecular Biochemistry, Pomeranian Medical University in Szczecin, Powstańców Wielkopolskich 72, 70-111 Szczecin, Poland.
J Clin Med. 2019 Feb 1;8(2):164. doi: 10.3390/jcm8020164.
There is a worldwide prevalence of generalized anxiety and major depressive disorders (MDD). Gut⁻brain axis dysfunction, antibacterial activity, and modulatory effects of antidepressants toward intestinal bacteria have been shown both in vitro and in vivo.
In this study, we aimed to investigate the effects of hospital stay, including escitalopram administration, on gut microbiota in patients with depressive episodes.
After admission to the hospital and 7-days washout from all medications the composition of fecal microbiota samples was evaluated at baseline (W0) and after 6 weeks (W6), using 16S rRNA sequencing. The study was conducted on 17 inpatients (52.9% females), who followed the same daily hospital routine, including a standard diet and received 5⁻20 mg daily doses of escitalopram.
At the end of treatment (W6), no change was observed in the Chao1 index. However, Shannon (median (Q1⁻Q3): W0 2.78 (2.67⁻3.02) vs. W6 3.11 (2.80⁻3.30)), and inverse Simpson (median (Q1⁻Q3): W0 9.26 (7.26⁻13.76) vs. W6 12.13 (9.17⁻15.73)) indices increased significantly compared to baseline values (False Discovery Rate () = 0.031 and = 0.011, respectively). We also found that between-subject W0 Bray⁻Curtis dissimilarities were significantly higher than W0⁻W6 within-subject dissimilarities (median (Q1⁻Q3): 0.68 (0.56⁻0.77) vs. 0.38 (0.35⁻0.52), two sided Mann⁻Whitney test < 0.00001. The within-subject dissimilarities did not depend on sex, age, BMI, illness duration and a daily dose of escitalopram. No significant differences between taxa levels, at the studied time points, were observed when adjusted for multiple hypotheses testing procedures.
We conclude that a six-week treatment in a psychiatric hospital setting resulted in increased alpha biodiversity in fecal microbiota, however its causal relationship with patients' mental health was not proved. We have also found that individual microbiome stability was not affected by hospitalization.
广泛性焦虑症和重度抑郁症(MDD)在全球范围内普遍存在。肠道-脑轴功能障碍、抗菌活性以及抗抑郁药对肠道细菌的调节作用已在体外和体内得到证实。
在本研究中,我们旨在调查住院(包括给予艾司西酞普兰)对抑郁发作患者肠道微生物群的影响。
入院并停用所有药物7天后,使用16S rRNA测序在基线(W0)和6周后(W6)评估粪便微生物群样本的组成。该研究对17名住院患者(52.9%为女性)进行,他们遵循相同的每日医院常规,包括标准饮食,并接受每日5-20毫克剂量的艾司西酞普兰。
治疗结束时(W6),Chao1指数未观察到变化。然而,香农指数(中位数(Q1-Q3):W0为2.78(2.67-3.02),W6为3.11(2.80-3.30))和逆辛普森指数(中位数(Q1-Q3):W0为9.26(7.26-13.76),W6为12.13(9.17-15.73))与基线值相比显著增加(错误发现率(FDR)分别为0.031和0.011)。我们还发现,受试者间W0的布雷-柯蒂斯差异显著高于受试者内W0-W6的差异(中位数(Q1-Q3):0.68(0.56-0.77)对0.38(0.35-0.52),双侧曼-惠特尼检验P<0.00001)。受试者内差异不取决于性别、年龄、BMI、病程和艾司西酞普兰的每日剂量。在对多个假设检验程序进行调整后,在所研究的时间点,分类水平之间未观察到显著差异。
我们得出结论,在精神病医院环境中进行为期六周的治疗导致粪便微生物群的α多样性增加,但其与患者心理健康的因果关系尚未得到证实。我们还发现个体微生物组稳定性不受住院影响。